← Open Payments lookup

EVERARDO MEJIA: Open Payments

NPI 1144491259 · EL MONTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,244 in 99 payments from 14 companies in 2025. Trend: 2023 $2,559 · 2024 $3,339 · 2025 $2,244

Food & beverage: $2,244
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.25$659
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$471
ABBVIE INC.11$254
E.R. Squibb & Sons, L.L.C.9$215
Neurocrine BioSciences, Inc.6$190
Teva Pharmaceuticals USA, Inc.8$151
Otsuka America Pharmaceutical, Inc.5$116
Novo Nordisk Inc2$43
Lilly USA, LLC2$39
Axsome Therapeutics, Inc.1$28

Products named: FANAPT, CAPLYTA, VRAYLAR, COBENFY, INGREZZA, REXULTI, UZEDY, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.